BACE1 gene promoter is differentially regulated: Detection of a novel promoter region for its cell type-specific regulation

Journal of Molecular Neuroscience

Volumn 28, Issue 2, 2006, Pages 193-210

  Lahiri, Debomoy K ^a   Maloney, Bryan ^a   Ge, Yuan Wen ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Alzheimer; Amyloid; Brain; DNA protein; Neuron; Promoter; Secretase; Transcription

Indexed keywords

BETA SECRETASE; BRAIN EXTRACT; DNA FRAGMENT; NUCLEAR PROTEIN;

ANIMAL CELL; ARTICLE; CELL TYPE; CONTROLLED STUDY; DNA FLANKING REGION; GEL MOBILITY SHIFT ASSAY; GENE ACTIVITY; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENE SEQUENCE; GENE VECTOR; HUMAN; HUMAN CELL; MOLECULAR MODEL; NONHUMAN; NORTHERN BLOTTING; PROMOTER REGION; PROTEIN BINDING; PROTEIN DNA INTERACTION; QUANTITATIVE ANALYSIS; RAT; REPORTER GENE; TRANSCRIPTION INITIATION SITE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; ASPARTIC ENDOPEPTIDASES; BRAIN; CELL LINE; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; MICE; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; PROTEIN BIOSYNTHESIS; RNA, MESSENGER;

ANIMALIA;

EID: 33646878079     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:28:2:193     Document Type: Article

References (49)

1. Acquati F., Accarino M., Nucci C., Fumagalli P., Jovine L., Ottolenghi S., and Taramelli R. (2000) The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the down critical region. FEBS Lett. 468, 59-64.
2. Asai M., Hattori C., Szabo B., Sasagawa N., Maruyama K., Tanuma S., and Ishiura S. (2003) Putative function of ADAM9, ADAM10, and ADAM17 as APP α-secretase. Biochem. Biophys. Res. Commun. 301, 231-235.
3. Barbiero L., Benussi L., Ghidoni R., Alberici A., Russo C., Schettini G., et al. (2003) BACE-2 is overexpressed in Down's syndrome. Exp. Neurol. 182, 335-345.
4. Bargou R. C. and Leube R. E. (1991) The synaptophysin-encoding gene in rat and man is specifically transcribed in neuroendocrine cells. Gene 99, 197-204.
5. Bennett B. D., Babu-Khan S., Loeloff R., Louis J. C., Curran E., Citron M., and Vassar R. (2000) Expression analysis of BACE2 in brain and peripheral tissues. J. Biol. Chem. 275, 20,647-20,651.
6. Benson D. A., Karsch-Mizrachi I., Lipman D. J., Ostell J., and Wheeler D. L. (2006) GenBank. Nucleic Acids Res. 34, D16-D20.
7. Christensen M. A., Zhou W., Qing H., Lehman A., Philipsen S., and Song W. (2004) Transcriptional regulation of BACE1, the β-amyloid precursor protein β-secretase, by Sp1. Mol. Cell. Biol. 24, 865-874.
8. Clarimon J., Bertranpetit J., Calafell F., Boada M., Tarraga L., and Comas D. (2003) Association study between Alzheimer's disease and genes involved in Aβ biosynthesis, aggregation and degradation: suggestive results with BACE1. J. Neurol. 250, 956-961.
9. De Pietri Tonelli D., Mihailovich M., Di Cesare A., Codazzi F., Grohovaz F., and Zacchetti D. (2004) Translational regulation of BACE-1 expression in neuronal and non-neuronal cells. Nucleic Acids Res. 32, 1808-1817.
10. Ehehalt R., Michel B., De Pietri Tonelli D., Zacchetti D., Simons K., and Keller P. (2002) Splice variants of the β-site APP-cleaving enzyme BACE1 in human brain and pancreas. Biochem. Biophys. Res. Commun. 293, 30-37.
11. Farzan M., Schnitzler C. E., Vasilieva N., Leung D., and Choe H. (2000) BACE2, a β-secretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor protein. Proc. Natl. Acad. Sci. U. S. A. 97, 9712-9717.
12. Ge Y. W., Maloney B., Sambamurti K., and Lahiri D. K. (2004) Functional characterization of the 5′ flanking region of the BACE gene: identification of a 91 bp fragment involved in basal level of BACE promoter expression. FASEB J. 18, 1037-1039.
13. Ghosh C., Song W., and Lahiri D. K. (2000) Efficient DNA transfection in neuronal and astrocytic cell lines. Mol. Biol. Rep. 27, 113-121.
14. Gold G., Blouin J. L., Herrmann F. R., Michon A., Mulligan R., Duriaux Sail G., et al. (2003) Specific BACE1 genotypes provide additional risk for late-onset Alzheimer disease in APOEε4 carriers. Am. J. Med. Genet. 119B, 44-47.
15. Hardy J. and Selkoe D. J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
16. Hartmann T., Bieger S. C., Bruhl B., Tienari P. J., Ida N., Allsop D., et al. (1997) Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides. Nat. Med. 3, 1016-1020.
17. Hussain I., Powell D., Howlett D. R., Tew D. G., Meek T. D., Chapman C., et al. (1999) Identification of a novel aspartic protease (Asp 2) as β-secretase. Mol. Cell. Neurosci. 14, 419-427.
18. Isacson O., Seo H., Lin L., Albeck D., and Granholm A. C. (2002) Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and ACh. Trends Neurosci. 25, 79-84.
19. Jacobs G. H., Rackham O., Stockwell P. A., Tate W., and Brown C. M. (2002) Transterm: a database of mRNAs and translational control elements. Nucleic Acids Res. 30, 310-311.
20. Kitazume S., Nakagawa K., Oka R., Tachida Y., Ogawa K., Luo Y., et al. (2005) In vivo cleavage of α2,6-sialyl-transferase by Alzheimer βsecretase. J. Biol. Chem. 280, 8589-8595.
21. La Fauci G., Lahiri D. K., Salton S. R. and Robakis N. K. (1989) Characterization of the 5′-end region and the first two exons of the βprotein precursor gene. Biochem. Biophys. Res. Commun. 159, 297-304.
22. Lahiri D. K. (2004) Unraveling nature's secrets, from neurons and memory to brain disorders: exploring the new frontier of Alzheimer's disease. Curr. Alz. Res. 1, 1.
23. Lahiri D. K., Alley G. M., Ge Y. W., and Du Y. (2002) Functional characterization of the 5′-regulatory region of the murine apolipoprotein gene. Ann. N. Y. Acad. Sci. 973, 340-344.
24. Lahiri D. K. and Robakis N. K. (1991) The promoter activity of the gene encoding Alzheimer βamyloid precursor protein (APP) is regulated by two blocks of upstream sequences. Brain Res. Mol. Brain Res. 9, 253-257.
25. Lahiri D. K., Farlow M. R., Sambamurti K., Greig N. H., Giacobini E., and Schneider L. S. (2003) A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease. Curr. Drug Targets 4, 97-112.
26. Lahiri D. K., Maloney B., and Ge Y.-W. (2006) Functional domains of the BACE1 and BACE2 promoters and mechanisms of transcriptional suppression of the BACE2 promoter in normal neuronal cells. J. Mol. Neurosci. 29(1), in press.
27. Lahiri D. K., Ge Y.- W., and Maloney B. (2005a) Characterization of the APP proximal promoter and 5′-untranslated regions: identification of cell-type specific domains and implications in APP gene expression and Alzheimer's disease. FASEB J. 19, 653-655.
28. Lahiri D. K., Wavrant De-Vrieze F., Ge Y.- W., Maloney B., and Hardy J. (2005b) Characterization of two APP gene promoter polymorphisms that appear to influence risk of late-onset Alzheimer's disease. Neurobiol. Aging 26, 1329-1341.
29. Lahiri D. K., Xu Y., Klaunig J., Baiyewu O., Ogunniyi A., Hall K., et al. (1999) Effect of oxidative stress on DNA damage and βamyloid precursor proteins in lymphoblastoid cell lines from a Nigerian population. Ann. N. Y. Acad. Sci. 893, 331-336.
30. Ling Y., Morgan K., and Kalsheker N. (2003) Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease. Int. J. Biochem. Cell. Biol. 35, 1505-1535.
31. Luckow B. and Schutz G. (1987) CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15, 5490.
32. Maloney B., Ge Y. W., Greig N., and Lahiri D. K. (2004) Presence of a "CAGA box" in the APP gene unique to amyloid plaque-forming species and absent in all APLP-1/2 genes: implications in Alzheimer's disease. FASEB J. 18, 1288-1290.
33. Motonaga K., Itoh M., Becker L. E., Goto Y., and Takashima S. (2002) Elevated expression of β-site amyloid precursor protein cleaving enzyme 2 in brains of patients with Down syndrome. Neurosci. Lett. 326, 64-66.
34. Ohno M., Sametsky E. A., Younkin L. H., Oakley H., Younkin S. G., Citron M., et al. (2004) BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease. Neuron 41, 27-33.
35. Prasher V. P., Farrer M. J., Kessling A. M., Fisher E. M., West R. J., Barber P. C., and Butler A. C. (1998) Molecular mapping of Alzheimer-type dementia in Down's syndrome. Ann. Neurol. 43, 380-383.
36. Salbaum J. M., Weidemann A., Lemaire H. G., Masters C. L., and Beyreuther K. (1988) The promoter of Alzheimer's disease amyloid A4 precursor gene. EMBO J. 7, 2807-2813.
37. Sambamurti K., Kinsey R., Maloney B., Ge Y. W., and Lahiri D. K. (2004) Gene structure and organization of the human βsecretase (BACE) promoter. FASEB J. 18, 1034-1036.
38. Satoh J. and Kuroda Y. (2000) Amyloid precursor protein β-secretase (BACE) mRNA expression in human neural cell lines following induction of neuronal differentiation and exposure to cytokines and growth factors. Neuropathology 20, 289-296.
39. Sauerwald A., Hoesche C., Oschwald R., and Kilimann M. W. (1990) The 5′-flanking region of the synapsin I gene. A G+C-rich, TATA- and CAAT-less, phylogenetically conserved sequence with cell type-specific promoter function. J. Biol. Chem. 265, 14,932-14,937.
40. Selkoe D. J. (2003) Aging, amyloid, and Alzheimer's disease: a perspective in honor of Carl Cotman. Neurochem. Res. 28, 1705-1713.
41. Selkoe D. J. (2004) Alzheimer disease: mechanistic understanding predicts novel therapies. Ann. Intern. Med. 140, 627-638.
42. Sinha S., Anderson J. P., Barbour R., Basi G. S., Caccavello R., Davis D., et al. (1999) Purification and cloning of amyloid precursor protein β-secretase from human brain. Nature 402, 537-540.
43. Solans A., Estivill X., and de La Luna S. (2000) A new aspartyl protease on 21q22.3, BACE2, is highly similar to Alzheimer's amyloid precursor protein β-secretase. Cytogenet. Cell Genet. 89, 177-184.
44. Song W. and Lahiri D. K. (1998) Functional identification of the promoter of the gene encoding the Rhesus monkey β-amyloid precursor protein. Gene 217, 165-176.
45. Strausberg R. L., Feingold E. A., Grouse L. H., Derge J. G., Klausner R. D., Collins F. S., et al. (2002) Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. U. S. A. 99, 16,899-16,903.
46. Tanahashi H. and Tabira T. (2001) Three novel alternatively spliced isoforms of the human β-site amyloid precursor protein cleaving enzyme (BACE) and their effect on amyloid β-peptide production. Neurosci. Lett. 307, 9-12.
47. Thiel G., Greengard P., and Sudhof T. C. (1991) Characterization of tissue-specific transcription by the human synapsin I gene promoter. Proc. Natl. Acad. Sci. U. S. A. 88, 3431-3435.
48. Vassar R., Bennett B. D., Babu-Khan S., Kahn S., Mendiaz E. A., Denis P., et al. (1999) β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741.
49. Yan R., Bienkowski M. J., Shuck M. E., Miao H., Tory M. C., Pauley A. M., et al. (1999) Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity. Nature 402, 533-537.